STING antagonist-loaded renal tubule epithelial cell-mimicking nanoparticles ameliorate acute kidney injury by orchestrating innate and adaptive immunity
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: interferon and immune responses · Viral Infections and Outbreaks Research · Mosquito-borne diseases and control
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Acute kidney injury10.1038/s41572-021-00284-z ↗
2. World incidence of AKI: a meta-analysis10.2215/CJN.00710113 ↗
3. Acute kidney injury and chronic kidney disease as interconnected syndromes10.1056/NEJMra1214243 ↗
4. Raising awareness of acute kidney injury: a global perspective of a silent killer10.1038/ki.2013.153 ↗
5. Immune cells in experimental acute kidney injury10.1038/nrneph.2014.180 ↗
6. ROS-p53-cyclophilin-D signaling mediates salinomycin-induced glioma cell necrosis10.1186/s13046-015-0174-1 ↗
7. Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions10.1016/j.redox.2021.102065 ↗
8. Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex10.1038/s41467-017-02325-2 ↗
9. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release10.1152/physrev.00026.2013 ↗
10. Novel signaling axis for ROS generation during K-Ras-induced cellular transformation10.1038/cdd.2014.34 ↗
11. Circulating mitochondrial DNA stimulates innate immune signaling pathways to mediate acute kidney injury
12. Mitochondrial quality control in kidney injury and repair10.1038/s41581-020-00369-0 ↗
13. Structures and mechanisms in the cGAS-STING innate immunity pathway10.1016/j.immuni.2020.05.013 ↗
14. Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure10.1172/JCI200112080 ↗
15. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury10.1152/ajprenal.00432.2002 ↗
16. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury10.1038/ki.2009.259 ↗
17. The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases Aβ clearance in 5XFAD mice10.1016/j.ebiom.2023.104713 ↗
18. Chronic ethanol induces a pro-inflammatory switch in interleukin-1β regulation of GABAergic signaling in the medial prefrontal cortex of male mice10.1016/j.bbi.2023.02.020 ↗
19. Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis10.1016/j.cmet.2019.08.003 ↗
20. Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury10.1016/j.celrep.2019.09.050 ↗
21. Cell membrane coating nanotechnology10.1002/adma.201706759 ↗
22. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery10.1021/nl500618u ↗
23. Biomimetic nanoparticles enabled by cascade cell membrane coating for direct cross-priming of T cells
24. Biomimetic immunomodulation by crosstalk with nanoparticulate regulatory T cells10.1016/j.matt.2021.08.015 ↗
25. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses10.1016/j.immuni.2007.05.016 ↗
26. Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H110.1111/j.1523-1755.2005.00665.x ↗
27. Activated human renal tubular cells inhibit autologous immune responses10.1093/ndt/gfq677 ↗
28. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform10.1073/pnas.1106634108 ↗
29. Targeting STING with covalent small-molecule inhibitors10.1038/s41586-018-0287-8 ↗
30. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney10.1038/ki.1994.6 ↗
31. Unraveling cell-type-specific targeted delivery of membrane-camouflaged nanoparticles with plasmonic imaging10.1021/acs.nanolett.0c01503 ↗
32. Extracellular vesicle-encapsulated IL-10 as novel nanotherapeutics against ischemic AKI10.1126/sciadv.aaz0748 ↗
33. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer10.1038/s41467-022-30568-1 ↗
34. A renal YY1-KIM1-DR5 axis regulates the progression of acute kidney injury10.1038/s41467-023-40036-z ↗
35. Acute kidney injury-epidemiology, outcomes and economics10.1038/nrneph.2013.282 ↗
36. Pathophysiology of AKI to CKD progression10.1016/j.semnephrol.2020.01.011 ↗
37. Deletion of myeloid interferon regulatory factor 4 (irf4) in mouse model protects against kidney fibrosis after ischemic injury by decreased macrophage recruitment and activation10.1681/ASN.2020071010 ↗
38. Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury10.1016/j.kint.2021.09.033 ↗
39. Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury10.1016/j.kint.2020.01.036 ↗
40. Supramolecular nanofibers containing arginine-glycine-aspartate (RGD) peptides boost therapeutic efficacy of extracellular vesicles in kidney repair10.1021/acsnano.0c05681 ↗
41. ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule10.1126/sciadv.abb7422 ↗
42. DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury10.1038/s41551-018-0317-8 ↗
43. Mesenchymal stem cell-derived extracellular vesicles attenuate mitochondrial damage and inflammation by stabilizing mitochondrial DNA10.1021/acsnano.0c08947 ↗
44. Kim-1 targeted extracellular vesicles: a new therapeutic platform for RNAi to treat AKI10.1681/ASN.2020111561 ↗
45. Detection of microbial infections through innate immune sensing of nucleic acids10.1146/annurev-micro-102215-095605 ↗
46. Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing10.1038/ni.3558 ↗
47. Cancer-cell-biomimetic nanoparticles for targeted therapy of homotypic tumors10.1002/adma.201602173 ↗
48. Targeted noninvasive treatment of choroidal neovascularization by hybrid cell-membrane-cloaked biomimetic nanoparticles10.1021/acsnano.1c00680 ↗
49. Wnt/β-catenin-promoted macrophage alternative activation contributes to kidney fibrosis10.1681/ASN.2017040391 ↗
50. Distinct macrophage phenotypes contribute to kidney injury and repair10.1681/ASN.2009060615 ↗
51. M2 macrophage hybrid membrane-camouflaged targeted biomimetic nanosomes to reprogram inflammatory microenvironment for enhanced enzyme-thermo-immunotherapy
52. Neutrophil membrane engineered HucMSC sEVs alleviate cisplatin-induced AKI by enhancing cellular uptake and targeting10.1186/s12951-022-01574-8 ↗